Showing 1 - 20 results of 21,342 for search 'significant ((((((ratio decreased) OR (we decrease))) OR (_ decrease))) OR (a decrease))', query time: 0.43s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Supplementary file 1_Intercropping of short- and tall-stature maize decreases lodging risk without yield penalty at high planting density.docx by Jianhong Ren (2186293)

    Published 2025
    “…Lodging rate of sole XY under normal and high density was 4.3% and 22.0% in 2021, but lodging was absent for ZD and intercropped XY, which demonstrated that the lodging resistance of intercropped XY was significantly enhanced. This study presents a strategy to enhance maize lodging resistance without yield penalty or requiring additional inputs.…”
  7. 7
  8. 8

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  9. 9
  10. 10
  11. 11
  12. 12

    Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx by Le Zhang (88249)

    Published 2025
    “…Additionally, a significant correlation between Chl-a concentration and SSC was found. …”
  13. 13
  14. 14

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
  15. 15

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
  16. 16

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
  17. 17
  18. 18
  19. 19
  20. 20